The Technical Analyst
Inspira Technologies Oxy [IINN]
Exchange: NASDAQ Sector: Healthcare Industry: Medical Devices
Inspira Technologies Oxy Price, Forecast, Insider, Ratings, Fundamentals & Signals
Current Signal: BUY (auto-tracking)
-4.74% $1.810
America/New_York / 18 apr 2024 @ 16:00
| FUNDAMENTALS | |
|---|---|
| MarketCap: | 31.30 mill |
| EPS: | -0.930 |
| P/E: | -1.950 |
| Earnings Date: | Mar 18, 2024 |
| SharesOutstanding: | 17.29 mill |
| Avg Daily Volume: | 1.190 mill |
| RATING 2024-04-18 |
|---|
| B- |
| Neutral |
| RATINGS | ||
|---|---|---|
| Rating CashFlow: | Neutral | |
| Return On Equity: | Strong Sell | |
| Return On Asset: | Strong Sell | |
| DE: | Buy | |
| P/E: | Buy | |
| Price To Book: | Sell |
| QUARTER GROWTHS | ||||||
|---|---|---|---|---|---|---|
| 3/22 | 4/22 | 1/23 | 2/23 | 3/23 | 4/23 | |
| Revenue | n/a | n/a | n/a | n/a | n/a | |
| Gr.Profit | n/a | n/a | n/a | n/a | n/a | |
| Ebit | ||||||
| Asset | ||||||
| Debt |
| PE RATIO: COMPANY / SECTOR |
|---|
| 0.00x |
| Company: PE -1.950 | sector: PE -3.05 |
| PE RATIO: COMPANY / INDUSTRY |
|---|
| -0.01x |
| Company: PE -1.950 | industry: PE 222.16 |
| DISCOUNTED CASH FLOW VALUE |
|---|
|
$0.230 (-87.29%) $-1.580 |
| Date: 2024-04-19 |
| Expected Trading Range (DAY) |
|---|
|
$ 1.657 - 1.963 ( +/- 8.45%) |
| ATR Model: 14 days |
Forecast:
16:00 - $1.810
Live Trading Signals (every 1 min)
Forecast
1: 16:00 - $1.810
Forecast 2: 16:00 - $1.810
Forecast 3: 16:00 - $1.810
SCORE
10.00
Buy
10.00
Buy
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Last version updated: Fri April 15th, 2022
| Indicator Signals | |
|---|---|
| RSI 21 | |
| SMA | |
| Trend | |
| Trend 2 | |
| Trend 3 | |
| MACD |
| Volume Signals | |
|---|---|
| Price | $1.810 (-4.74% ) |
| Volume | 0.0851 mill |
| Avg. Vol. | 1.190 mill |
| % of Avg. Vol | 7.15 % |
| Signal 1: | |
| Signal 2: |
Today
Last 12 Months
RSI
Last 10 Buy & Sell Signals For IINN
0 Signals | Accuracy: 0.00% | Accuracy Buy: 0.00% | Accuracy Sell: 0.00%
Avg return buy: 0.00 % | Avg return sell: 0.00 %
$1 invested is now $1.00 or 0.00% since Coming Soon
| Date | Signal | @ | Closed | % | Feb 14 - 10:45 | buy | $1.261 | N/A | Active |
|---|
IINN
Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.
Last 10 Buy Signals
Latest Press Releases
2024-04-16 08:42:00 - Press Release
Inspira™ Signs Term Sheet For Use Of Inspira™ Art100 Device In Organ Transplant Procedures
Ra'anana, israel , april 16, 2024 /prnewswire/ -- inspira™ technologies oxy b.h.n. ltd. (nasdaq: iinn) (nasdaq: iinnw) (the "company" or "inspira"), a breakthrough medical technology company, is proud to announce the signing of a collaboration term sheet (the "term sheet") with the beilinson hospital in israel for the evaluation of its proprietary inspira art100 device (the "device") in organ transplant procedures.
2024-04-10 08:24:00 - Press Release
Inspira™ And Ennocure In Vitro Study Results Show 100% Prevention Of Bacterial Growth That Causes Bloodstream Infections
Ra'anana, israel , april 10, 2024 /prnewswire/ -- inspira™ technologies oxy b.h.n. ltd. (nasdaq: iinn) (nasdaq: iinnw) (the "company" or "inspira"), a breakthrough medical technology company, together with ennocure medtech ltd.
2024-04-03 08:30:00 - Press Release
Inspira™ Announces Program To Pioneer The Applicable Use Of The Inspira™ Art100 Device For An Artificial Womb
Ra'anana, israel , april 3, 2024 /prnewswire/ -- inspira™ technologies oxy b.h.n. ltd. (nasdaq: iinn) (nasdaq: iinnw) (the "company" or "inspira"), a breakthrough medical technology company, is delighted to announce the commencement of a program to explore the applicable use of the inspira™ art100 device for an artificial womb for neonates in need of vital respiratory support.
2024-04-01 08:00:00 - Press Release
Inspira™ Announces $1.65 Million Registered Direct Offering Of Ordinary Shares By Inspira Ceo's Mother With Leading Fund Manager
Ra'anana, israel , april 1, 2024 /prnewswire/ -- inspira technologies oxy b.h.n. ltd. (nasdaq: iinn, iinnw) (the "company" or "inspira"), today announced a strategic investment by leading investor, mr.
2024-03-25 09:20:00 - Press Release
Inspira™ Technologies Reports Full Year 2023 Financial Results
Fda submission for approval of inspira™ art100 95% accuracy results for hyla™ blood sensor compared to standard blood gas analyzers granted u.s. patent for inspira™ art medical device ra'anana, israel , march 25, 2024 /prnewswire/ -- inspira technologies oxy b.h.n. ltd. (nasdaq: iinn) (nasdaq: iinnw) (the "company" or "inspira technologies"), a breakthrough medical technology company, today announced its financial results for the year ended december 31, 2023.
Latest News
2024-03-19 14:11:04 - Zacks Investment Research
Inspira Technologies (IINN) Strives to Get AMAR Nod for ART100
The AMAR submission is a strategic move by Inspira Technologies (IINN), positioning it to target global markets with its innovative Augmented Respiration Technology (INSPIRA ART).
2024-03-14 11:21:04 - Zacks Investment Research
Inspira Technologies (IINN) Releases Favorable Data on VORTX
Inspira Technologies' (IINN) proprietary orbiting oxygenation technology eliminates the need for membrane fibers, thereby reducing pressure differentials and high shear stress.
2024-03-04 09:20:00 - PRNewsWire
Inspira™ Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within Days
The major milestone refers to Inspira's proprietary technology to oxygenate blood for the INSPIRA™ ART (Gen 2). This patented tech is considered by Inspira to be a game-changer and also aims to replace technologies used today by current medical device companies.
2024-02-27 07:02:00 - PRNewsWire
Inspira™ To Host Conference Call to Discuss Investor Presentation and Announce Next Major Milestone
RA'ANANA, Israel , Feb. 27, 2024 /PRNewswire/ -- Inspira™ Technologies OXY B.H.N. Ltd. (Nasdaq: IINN) (Nasdaq: IINNW) (the "Company" or "Inspira Technologies"), a breakthrough medical technology company, announced today that the Company President, Director and co-founder, Mr.
2023-11-30 12:49:12 - Zacks Investment Research
Inspira (IINN) Expands in Life Support Space With New Deal
According to Inspira (IINN), the integration of its technology to oxygenate blood combined with Ennocure's infection prevention solutions is likely to help improve patient outcomes in ICUs.
2023-08-31 12:02:12 - Zacks Investment Research
Inspira (IINN) Advances Foothold in Europe With Extended Deal
The extended service agreement complements a previously announced strategic agreement between Inspira (IINN) and Innovimed.
2023-04-24 08:30:00 - Accesswire
Inspira(TM) Technologies to Present at the Planet MicroCap Showcase 2023 on Wednesday, April 26, 2023 in Las Vegas
RA'ANANA, ISRAEL / ACCESSWIRE / April 24, 2023 / Inspira™ Technologies OXY B.H.N. Ltd. (NASDAQ:IINN)(NASDAQ:IINNW) (the "Company" or "Inspira Technologies"), a company aiming to revolutionize acute respiratory care, has announced today that Joe Hayon, President and Co-Founder of Inspira Technologies, will present at the 2023 Planet MicroCap Showcase in Las Vegas this week on Wednesday at 14:30 CST, April 26, 2023.
2022-07-06 17:28:03 - Benzinga
Why Inspira Technologies Stock Soared Today
Inspira Technologies Oxy BHN Ltd (NASDAQ: IINN) shares closed up76.6% at $2.19 Wednesday after the company announced it developed a non-invasive blood sensor designated to alert real-time change in patients' clinical condition. Inspira's blood sensor, HYLA, is.
2022-07-06 11:54:06 - InvestorPlace
Why Is Inspira Technologies (IINN) Stock Up 100% Today?
As Inspira Technologies advances a new blood sensor with the potential to change patient outcomes, IINN stock is quickly heading north. The post Why Is Inspira Technologies (IINN) Stock Up 100% Today?
2022-02-02 12:17:25 - PennyStocks
3 Hot Penny Stocks to Watch Under $4 Right Now
Here are three penny stocks to check out today The post 3 Hot Penny Stocks to Watch Under $4 Right Now appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.